This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Innavirvax. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Dominique Desfontaines
Introduction
Dominique Desfontaines is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines against HIV. His work is characterized by a commitment to advancing medical science and improving public health.
Latest Patents
Dominique Desfontaines holds a patent for an immunogenic compound comprising an HIV GP41 peptide coupled to a CRM197 carrier protein. This invention relates to vaccines aimed at viruses of the HIV family. The immunogenic compound is designed to prevent and treat conditions caused by HIV infection. The specific formula of the peptide is NH2-[Nt]y-P-W-N-X-S-X2-S-N-X3-X4-X-X6-X7-I-W-[Ct]z-COOH, which is covalently linked to the CRM197 protein.
Career Highlights
Throughout his career, Desfontaines has worked with various companies, including Innavirvax and Minka Therapeutics. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Joël Crouzet and Raphaël Ho Tsong Fang. Their collaborative efforts have furthered the development of innovative solutions in the fight against viral infections.
Conclusion
Dominique Desfontaines is a prominent figure in the field of immunology, with a focus on HIV vaccine development. His patent and collaborations reflect his dedication to advancing medical research and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile